Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,782 total articles

Turbo Energy and Hithium Partner to Integrate AI-Driven Energy Optimization Software Into Battery Storage Systems Across Europe and Latin America

Turbo Energy and Hithium Partner to Integrate AI-Driven Energy Optimization Software Into Battery Storage Systems Across Europe and Latin America

Turbo Energy announced a strategic partnership with Hithium to integrate its AI-driven energy optimization platform into Hithium's battery storage systems. This collaboration aims to deploy intelligent energy storage solutions for commercial and industrial sectors in Europe and Latin America, enhancing efficiency, operational resilience, and reduci…

Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions

Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions

Helus Pharma, a clinical stage pharmaceutical company developing novel serotonergic agonists (NSAs), welcomed the White House Executive Order aimed at advancing psychedelic research and regulatory pathways for treating serious mental health disorders. The Executive Order encourages FDA prioritization, expanded patient access, increased funding, and…

Nanox Signs Commercial Agreement with Howard Technology Solutions to Deploy 300 Nanox.ARC Systems Across U.S. Over Three Years

Nanox Signs Commercial Agreement with Howard Technology Solutions to Deploy 300 Nanox.ARC Systems Across U.S. Over Three Years

Nano-X Imaging Ltd. announced a strategic commercial agreement with Howard Technology Solutions to market and deploy 300 FDA-cleared Nanox.ARC 3D digital tomosynthesis imaging systems across U.S. healthcare and public sector facilities over the next three years. This partnership leverages Howard's national reach and expertise to expand Nanox's pres…

Foresight Enters Non-Binding Term Sheet for $17.5 Million Strategic Investment at Significant Premium to Current Market Price and Focus on Defense Collaboration

Foresight Enters Non-Binding Term Sheet for $17.5 Million Strategic Investment at Significant Premium to Current Market Price and Focus on Defense Collaboration

Foresight Autonomous Holdings Ltd. has signed a non-binding term sheet with VisionWave Holdings, Inc. for a strategic equity investment of up to $17.5 million, valuing Foresight at approximately $35 million, a threefold premium to its current market value. The investment aims to strengthen Foresight's financial position and accelerate development a…

YY Group Reports Unaudited Second Half and Full Year 2025 Earnings Results Highlighting Accelerating Revenue Growth, Expanding Margins and Positioning for Profitability in 2026

YY Group Reports Unaudited Second Half and Full Year 2025 Earnings Results Highlighting Accelerating Revenue Growth, Expanding Margins and Positioning for Profitability in 2026

YY Group Holding Limited announced robust unaudited financial results for full year 2025, with a 39.3% increase in revenue to $57.2 million and a 50.2% rise in gross profit, driven by growth in manpower and integrated facilities management (IFM) segments. The company undertook strategic investments, acquisitions, and geographic expansion across Asi…

Safe Pro Reports on Share Repurchase Program, Reinforcing Commitment to Shareholder Value and Capital Return

Safe Pro Reports on Share Repurchase Program, Reinforcing Commitment to Shareholder Value and Capital Return

Safe Pro Group Inc. is actively executing a $3 million authorized share repurchase program, having repurchased 400,000 shares to date. Funded by strong cash flow and a solid balance sheet with no debt, the buyback underscores management's confidence in the company's intrinsic value, AI-enabled defense solutions growth, and long-term outlook. The pr…

Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer

Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer

Helus Pharma, a clinical-stage pharmaceutical company developing novel serotonergic agonists for mental health conditions, announced the immediate resignation of CEO Michael Cola. Co-founder and Executive Chairman Eric So will resume his role as interim CEO while a search for a permanent replacement is underway. The company continues to focus on ad…

Genius Group Receives ICC Arbitration Award, Wins Return of 7.4 Million Shares and $8.0 Million Cash Payment

Genius Group Receives ICC Arbitration Award, Wins Return of 7.4 Million Shares and $8.0 Million Cash Payment

Genius Group Limited (NYSE American: GNS), an AI-powered education company, announced it has won a final ICC arbitration award against LZG International, entitling it to the return of approximately 7.4 million shares of its common stock and a cash payment of nearly $8 million. The company is pursuing enforcement and further legal actions related to…

ZJK Industrial Co., Ltd. Advances Localization Strategy in Vietnam to Strengthen Global Production Network

ZJK Industrial Co., Ltd. Advances Localization Strategy in Vietnam to Strengthen Global Production Network

ZJK Industrial Co., Ltd., a NASDAQ-listed high-tech precision parts manufacturer, announced advancement of its localization strategy through its Vietnamese subsidiary, ZJK Vietnam Precision Components Co. The new facility focuses on R&D and production of precision components for sectors like AI infrastructure, electronics, and automotive, aiming to…

Callan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure

Callan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure

Callan JMB Inc. announced the development of Atlas Complex, a 150-acre pharmaceutical, medical, and logistics campus in Marion, Alabama. The facility will support pharmaceutical onshoring, early-stage production, QA/QC, cold-chain logistics, and domestic distribution. Partnering with Monarch Property Management and Walker's Pharmaceuticals of India…

Fusion Fuel Highlights Announced Exploration Plan at Jaguar Uranium’s Huemul Project, Potential Royalty Portfolio Income

Fusion Fuel Highlights Announced Exploration Plan at Jaguar Uranium’s Huemul Project, Potential Royalty Portfolio Income

Fusion Fuel Green PLC announced its planned acquisition of a controlling interest in Royal Uranium Inc., which holds a 1.0% NSR royalty on the Huemul Project in Argentina. This strategic move provides Fusion Fuel capital-efficient exposure to uranium, copper, and vanadium resources at a historically significant mining district. Jaguar Uranium's exp…

MainStreet Bancshares, Inc. Announces First Quarter 2026 Results

MainStreet Bancshares, Inc. Announces First Quarter 2026 Results

MainStreet Bancshares, Inc. reported a net income of $4.1 million for Q1 2026, with EPS of $0.48, driven by a 9 basis point expansion in net interest margin to 3.47%. The company executed a buyback of over 273,000 shares, strengthened its capital position, increased net loans to $1.85 billion, and maintained a strong 98% loan-to-deposit ratio. Depo…

Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve

Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve

Axe Compute Inc., a NASDAQ-listed AI infrastructure platform, announced the launch of its Strategic Compute Reserve (SCR) Dashboard. The dashboard consolidates detailed, real-time insights into the company's GPU asset reserves and stock metrics, improving transparency by integrating the equity valuation with the value and unlock schedule of its AI …

Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Calidi Biotherapeutics presented new compelling data demonstrating the effectiveness of its RedTail virotherapy platform, which systemically delivers targeted genetic medicines for cancer treatment. The company highlighted its lead candidate CLD-401 and introduced CLD-501 targeting TROP2, aiming to improve T-cell engagers' efficacy in solid tumors …

Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks

Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks

Kyverna Therapeutics reported positive longer-term follow-up data from the Phase 2 portion of its KYSA-6 trial evaluating mivocabtagene autoleucel (miv-cel), a CAR T therapy, in patients with generalized myasthenia gravis (gMG). The data demonstrate rapid, robust, and sustained clinical improvements through 52 weeks after a single dose, with all pa…

BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure

BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure

BioCardia announced a favorable outcome from its clinical consultation with Japan's PMDA for CardiAMP Cell Therapy, signaling likely sufficiency of its clinical data to support regulatory approval for ischemic heart failure treatment in Japan. The company is positioned to become the first to offer a minimally invasive biologic therapy for this cond…